This enterprise functions as an investment holding company, with its core business centered on crafting and distributing skincare solutions. Operating under the "Park Ha" brand, these products are sold across the People's Republic of China. The company executes these activities through its affiliated subsidiaries, which manage both direct product sales and the provision of franchise services.
Portnoy Law Firm Announces Class Action on Behalf of Park Ha Biological Technology Co., Inc. Investors
The Portnoy Law Firm announced a class action on behalf of Park Ha Biological Technology (NASDAQ: PHH) investors who bought securities between Dec 27, 2024 and Jul 8, 2025.
The suit alleges Park Ha failed to disclose a fraudulent stock-promotion scheme involving social-media misinformation and an intentionally low-float IPO structure enabling manipulation.
Investors have until September 28, 2026 to move for lead plaintiff. This is a law-firm solicitation notice, not a new company disclosure.